anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Paragraph

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 118,471
Current window 34,531-34,560
Pages 3,950
Rows per page 30
Component: Paragraphclear collectionreset all
18 30 60

Component

34,531-34,560 of 118,471

filter-aware
14
The slide uses strong, accusatory language ('disaster', 'fraud', 'kickback scheme', 'whales') to frame the company's business model as unsustainable and illegal.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Monster2 hits
16
Uses historical precedent (Enron/Skilling and Insys) to frame current events at Harmony (HRMY) as a potential fraud or legal violation.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Monster2 hits
20
The slide uses a direct quote from an earnings call to highlight a lack of transparency and potential business risk.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment2 hits
24
The slide uses a Q&A format to present qualitative evidence of corporate malfeasance or short-termism.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment2 hits
32
The slide uses a narrative of past professional failure to cast doubt on current leadership.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle2 hits
34
The slide uses a WSJ article as a source to expose the CEO's attempt to distance himself from a controversial business practice.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle2 hits
36
The slide uses visual evidence (empty chair, press conference) to frame the subject as a villain in a political/regulatory context.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle2 hits
38
The slide uses a combination of summary text and a direct testimonial quote to establish a pattern of behavior.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle2 hits
41
The slide uses a Q&A format to highlight potential corporate malfeasance regarding clinical trial adverse events.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle2 hits
42
The slide uses highlighted text to emphasize key admissions regarding management's role in stopping the study.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle2 hits
49
Includes a process diagram showing the progression from hERG block to Torsades de Pointes.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle2 hits
50
The slide uses red underlining to emphasize key risk statements, likely to draw attention to the severity of the condition in the context of a drug evaluation.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The StruggleLoop · The Reveal2 hits
59
The slide highlights a fundamental design constraint in medicinal chemistry.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The VictoryLoop · The Reveal2 hits
61
The slide uses a combination of narrative text and a supporting data table to argue that certain structural features are predictive of drug safety risks.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Victory2 hits
62
The slide highlights the specific chemical challenge of nitrogen basicity in piperidine rings and the potential for fluorine to modulate pKa for improved safety.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Victory2 hits
65
The slide uses a 'before-after' or 'evidence-based' contradiction structure to undermine the value of the licensed asset.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Victory2 hits
67
The slide uses historical publication data to cast doubt on the quality of the drug pitolisant by highlighting that the inventor prioritized other compounds.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Victory2 hits
70
The slide uses a 'villain' framing by highlighting the industry-wide failure of a specific drug class.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Victory2 hits
79
The slide uses a forensic literature review approach to highlight historical concerns about the drug's safety profile (cardiotoxicity, bioavailability, etc.) that were allegedly ignored or suppressed.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
80
The slide uses a primary text block to summarize the contradiction, followed by a direct excerpt from a 2008 paper as evidence.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
81
The slide uses a direct quote from a scientific paper to undermine the viability of the drug candidate mentioned in the lower text block.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
84
The slide uses a Q&A transcript format to build a case against the efficacy of pitolisant based on historical failures at Abbott.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
92
The slide uses a Q&A transcript format to highlight a specific failure case study.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
98
The slide uses direct quotes from a J&J scientist to undermine the credibility of Bioprojet's research capabilities.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
99
The slide uses a combination of summary bullet points and direct quotes from a consultation call to discredit the competitor's scientific rigor.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
105
The slide uses a 'quote-and-critique' structure to expose potential data manipulation in clinical reporting.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
107
The slide uses an FDA review document to highlight a safety risk (QTc prolongation) that the company allegedly downplays.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
108
The slide uses a direct quote from a study to argue that 'malaise sensation' is a euphemism for 'fainting' (syncope) to downplay cardiotoxicity.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
168
Uses red circles and arrows to highlight specific text and images as evidence of contradiction.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
182
This is an activist short-seller deck slide attacking the credibility of a CEO.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits